References
- Ono S, Kitamura K, Maekawa M et al. Protective effect of R(-)-1- (benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia. Jpn J Pharmacol 1993; 62: 81–6.
- Ikeda K, Sakamoto T, Marubuchi S, Kawazoe Y, Terashima N, Iwasaki Y, Kinoshita M, Ons S, Nakagawa M, Watabe K. Oral administration of a neuroprotective compound T-588, prevents motoneuron degeneration after facial nerve avulsion in adult rats. Brain Res 2000; 858: 84–91.
- Iwasaki Y, Ikeda K, Ichikawa Y et al. T-588 enhances neurite outgrowth and choline acetyltransferase in cultured rat spinal ventral horn neurons. Neurochem Res 2002; 27: 225–228.
- Søreide AJ. Variations in the axon reaction after different types of nerve lesion. Acta Anat 1981; 110: 173–188.
- Wu W. Expression of nitric-oxide synthase (NOS) in injured CNS neurons as shown by NADPH diaphorase histochemistry. Exp Neurol 1993; 120: 153–159.
- Koliatsos VE, Price WL, Pardo CA, Price DL. Ventral root avulsion: an experimental model of death of adult motor neurons. J Comp Neurol 1994; 342: 35–44.
- Watabe K, Ohashi T, Sakamoto T et al. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 2000; 60: 511–519.
- Sakamoto T, Watabe K, Ohashi T et al. Adenoviral vector- mediated GDNF gene transfer prevents death of adult facial motoneurons. NeuroReport 2000; 11: 1857–1860.
- Sakamoto T, Kawazoe Y, Shen J-S et al. Adenoviral gene transfer of GDNF, BDNF and TGFb2, but not CNTF, cardiotrophin-1 or IGF1, protects injured adult motoneurons after facial nerve avulsion. J Neurosci Res 2003; 72: 54–64.
- Shimada K, Mitamura K, Kitama N. Quantitative determination of 25-hydroxyvitamin D3 3-sulphate in human plasma using high performance liquid chromatography. Biomed Chromatogr 1995; 9: 229–32.
- Streit WJ. An improved staining method for rat microglial cells using the lectin from Griffonica simplicifolia (GSA I-B4). J Histochem Cytochem 1990; 38: 1683–1686.
- Ono S, Maekawa M, Kimura T et al. Effects of T-588, a novel cognitive enhancer, on acetylcholine and monoamine releases and second-messenger systems in rats. Soc Neurosci Abstr 1995; 21: 947.
- Ono S, Yamafuji T, Chaki H et al. Effects of T-588, a novel cognitive enhancer, on various amnesia models in rodents. Soc Neurosci Abstr 1993; 19: 1234.
- Ono S, Maekawa M, Miyazaki H et al. Effects of T-588, a newly synthesized cognitive enhancer, on the central nervous system. Soc Neurosci Abstr 1994; 20: 152.
- Ono S, Yamafuji T, Chaki H et al. A new cognition-enhancing agent, (R)-(-)-1-(Benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylanimo) ethoxy]ethanol hydrochloride: effects on memory impairment in rats generated by cerebral immobilization and basal forebrain lesions. Biol Pharm Bull 1995; 18: 1779–1783.
- Kimura T, Tamura R, Kurimoto H, Ono T. Effects of T-588, a newly synthesized cognitive enhancer, on hippocampal CA1 neurons in rat brain tissue slices. Brain Res 1999; 831: 175–183.
- Ono S, Yamaguchi H, Narita H. T-588, a novel cognition enhancer, potentiates the effect of nerve growth factor in PC12 cells. Soc Neurosci Abstr 1997; 23: 57.
- Maekawa M, Ono S, Narita H et al. Stimulation of noradrenaline release by T-588, a cognitive enhancer, in PC12 cells. Jpn J Pharmacol 2000; 82: 59–66.
- Iwasaki Y, Ikeda K, Kinoshita M. T-588 protects spinal motor neurons from glutamate-mediated neurotoxicity. Ann Neurol 2002; 52 (Suppl 1): 55.
- Lowrie MB, Vrbova´ G. Dependence of postnatal motoneurones on their targets: review and hypothesis. Trend Neurosci 1992; 15: 80–84.
- Takuma K, Fujita T, Kimura Y et al. T-588 inhibits astrocyte apoptosis via mitogen activated protein kinase signal pathway. Eur J Pharmacol 2000; 399: 1–8.
- Hirata K, Nakagawa M, Urbano FJ et al. Reduced facilitation and vesicular uptake in crustacean and mammalian neuromuscular junction by T-588, a neuroprotective compound. Proc Natl Acad Sci USA 1999; 96: 14588–14593.